OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
RDX58

Redox Ltd

Specialty ChemicalsVerified

Redox Ltd maintains a strong liquidity position with a current ratio of 4.17, indicating the company can cover its short-term obligations more than four times over. The company's debt-to-equity ratio of 0.09 suggests a conservative capital structure with minimal leverage. However, the risk assessment notes that net cash is negative after subtracting total debt, indicating potential liquidity constraints. In terms of profitability, Redox Ltd generates a return on equity of 14.17% and a return on assets of 10.53%, which are strong indicators of efficient capital utilization and asset management. These returns are particularly notable given the company's operating income of 106.95 million AUD and net income of 77.10 million AUD. The company's gross profit margin of 21.6% (268.63 million AUD on 1.24 billion AUD revenue) suggests effective cost control in its production processes. Redox Ltd's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to operational and market-specific risks. The company's growth trajectory appears stable, with a free cash flow of 16.83 million AUD and capital expenditures of 5.12 million AUD in the latest reporting period. Analysts have assigned a mean price target of 3.45 AUD, with a median of 3.50 AUD, suggesting moderate optimism about the company's future performance. The mean recommendation of 2.00 (on a scale from 1=strong buy to 5=strong sell) indicates a generally positive outlook from analysts. The risk assessment highlights medium liquidity risk and low dilution risk, with no near-term pressure from share issuance or dilution. The company's capital structure remains stable, with no significant adjustments applied to its valuation metrics. No recent filings or transcripts have been provided in the available data to indicate material changes in the company's operations or strategy.

30-day price · RDX-0.35 (-10.5%)
Low$2.71High$3.45Close$2.98As of28 May, 00:00 UTC
Profile
CompanyRedox Ltd
TickerRDX.AX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Redox Ltd is a specialty chemicals company that produces and distributes chemical products for industrial applications.

Classification. Redox Ltd is classified in the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence.

Redox Ltd maintains a strong liquidity position with a current ratio of 4.17, indicating the company can cover its short-term obligations more than four times over. The company's debt-to-equity ratio of 0.09 suggests a conservative capital structure with minimal leverage. However, the risk assessment notes that net cash is negative after subtracting total debt, indicating potential liquidity constraints. In terms of profitability, Redox Ltd generates a return on equity of 14.17% and a return on assets of 10.53%, which are strong indicators of efficient capital utilization and asset management. These returns are particularly notable given the company's operating income of 106.95 million AUD and net income of 77.10 million AUD. The company's gross profit margin of 21.6% (268.63 million AUD on 1.24 billion AUD revenue) suggests effective cost control in its production processes. Redox Ltd's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to operational and market-specific risks. The company's growth trajectory appears stable, with a free cash flow of 16.83 million AUD and capital expenditures of 5.12 million AUD in the latest reporting period. Analysts have assigned a mean price target of 3.45 AUD, with a median of 3.50 AUD, suggesting moderate optimism about the company's future performance. The mean recommendation of 2.00 (on a scale from 1=strong buy to 5=strong sell) indicates a generally positive outlook from analysts. The risk assessment highlights medium liquidity risk and low dilution risk, with no near-term pressure from share issuance or dilution. The company's capital structure remains stable, with no significant adjustments applied to its valuation metrics. No recent filings or transcripts have been provided in the available data to indicate material changes in the company's operations or strategy.
Key takeaways
  • Redox Ltd maintains a conservative capital structure with a low debt-to-equity ratio of 0.09.
  • The company generates strong returns on equity (14.17%) and assets (10.53%), indicating efficient capital utilization.
  • Redox Ltd's liquidity position is robust, with a current ratio of 4.17, but net cash is negative after subtracting total debt.
  • Analysts have a generally positive outlook, with a mean price target of 3.45 AUD and a mean recommendation of 2.00.
  • The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "Operating margin is expected to remain stable due to consistent cost control and pricing power in the specialty chemicals market.",
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue$1.24B
Gross profit$268.6M
Operating income$106.9M
Net income$77.1M
R&D
SG&A
D&A
SBC
Operating cash flow$47.8M
CapEx-$5.1M
Free cash flow$16.8M
Total assets$732.2M
Total liabilities$187.9M
Total equity$544.3M
Cash & equivalents$42.8M
Long-term debt$50.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$544.3M
Net cash-$7.2M
Current ratio4.2
Debt/Equity0.1
ROA10.5%
ROE14.2%
Cash conversion62.0%
CapEx/Revenue-0.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricRDXActivity
Op margin8.6%5.5% medp25 -0.0% · p75 10.8%above median
Net margin6.2%4.1% medp25 0.1% · p75 8.8%above median
Gross margin21.6%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-0.4%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity9.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Observations
IR observations
Mean price target3.45 AUD
Median price target3.50 AUD
High price target3.55 AUD
Low price target3.30 AUD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.16 AUD
Last actual EPS0.15 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 02:36 UTC#657e754b
Market quoteclose AUD 2.97 · shares 0.53B diluted
no public URL
2026-05-23 02:37 UTC#78aa4111
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 04:18 UTCJob: 94eaab42